Actively Recruiting
Study of How Past Respiratory Viral Infections Affect Lung Inflammation Caused by Ozone Exposure in Adults Aged 18 to 55
Led by Robert Tighe, MD · Updated on 2026-05-15
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research investigates how past respiratory infections influence the risk of lung inflammation after exposure to environmental agents like ozone. The study focuses on adults aged 18 to 55 and aims to understand changes in lung immune cells, specifically macrophages, following these exposures. Participants are grouped based on their history of respiratory viral infections, including no infection, mild infection, or viral pneumonia recovery. Participants undergo an initial 1-day screening involving blood tests and breathing assessments. They then return for two separate 2-day testing series spaced 18 to 20 days apart. During these visits, participants experience inhaled challenges with either filtered air or ozone while performing alternating rest and treadmill walking for 135 minutes. After each challenge, lung evaluation includes blood draws, breathing tests, and bronchoscopy. Follow-up phone calls occur 24 hours after each test series. The study measures changes in specific lung macrophage populations at baseline and after the exposures. Participants are monitored for lung function and immune responses over about one to one-and-a-half months. The study includes safety monitoring and excludes individuals with ongoing lung issues or recent infections. The goal is to better understand lung inflammation related to environmental exposures and prior infections.
CONDITIONS
Brief Title
Macrophage Regulation of Ozone-Induced Lung Inflammation
Research Team
C
Claudia Salazar
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here